bf/NYSE:GKOS_icon.jpeg

NYSE:GKOS

Glaukos

  • Stock

83.54

−11.36%

−4.46

USD last updated 08/08 02:05:20

Last Close

88.00

07/08 22:30

Market Cap

6.05B

Beta: 1.24

Volume Today

4.56M

Avg: 391.41K

PE Ratio

−34.36

PFCF: −69.66

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. ...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -1-0.50.512018-12-312020-08-062021-12-312023-11-012024-11-04

    Revenue (Estimate*)

    50M100M150M200M250M300M350M2018-12-312020-08-062021-12-312023-11-012024-11-04

    *Estimate based on analyst consensus